Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Naloxegol Oxalate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 48,251Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Grünenthal continues US growth push with $250M acquisition of Valinor Pharma
    Grünenthal continues US growth push with $250M acquisition of Valinor Pharma

    23 Jul 2024

    //  Kevin Dunleavy FIERCE PHARMA

    https://www.fiercepharma.com/pharma/grunenthal-continues-its-us-growth-push-250m-acquisition-valinor-pharma

     Kevin Dunleavy FIERCE PHARMA
    23 Jul 2024
    Share Share
    RedHill and HealthCare Agree to Extinguish All RedHill's Debt Obligations
    RedHill and HealthCare Agree to Extinguish All RedHill's Debt Obligations

    06 Feb 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/redhill-biopharma-and-healthcare-royalty-agree-to-extinguish-all-redhills-debt-obligations-in-exchange-for-movantik-301739194.html

    PR NEWSWIRE
    06 Feb 2023
    Share Share
    Grunenthal and Kyowa Announce Collaboration for Established Medicines Portfolio
    Grunenthal and Kyowa Announce Collaboration for Established Medicines Portfolio

    25 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221124005096/en/Gr%C3%BCnenthal-and-Kyowa-Kirin-International-Announce-Joint-Venture-Collaboration-for-Established-Medicines-Portfolio

    BUSINESSWIRE
    25 Nov 2022
    Share Share
    RedHill Biopharma Introduces Three New Analyzes of Movantik Data
    RedHill Biopharma Introduces Three New Analyzes of Movantik Data

    08 Sep 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/redhill-biopharma-presenta-tres-nuevos-analisis-de-los-datos-de-movantik-en-painweek-2021-824281970.html

    PRNEWSWIRE
    08 Sep 2021
    Share Share
    RedHill Biopharma Presents Three New Analyses of Movantik Data at PAINWeek 2021
    RedHill Biopharma Presents Three New Analyses of Movantik Data at PAINWeek 2021

    07 Sep 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/redhill-biopharma-presents-three-new-analyses-of-movantik-data-at-painweek-2021-301370121.html

    PRNEWSWIRE
    07 Sep 2021
    Share Share
    AstraZeneca completes divestment of Movantik to RedHill Biopharma
    AstraZeneca completes divestment of Movantik to RedHill Biopharma

    02 Apr 2020

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=122189&sid=2

    PHARMABIZ
    02 Apr 2020
    Share Share